Xiamen Amoytop Biotech Co. Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003RT3
CNY
57.16
0.38 (0.67%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
797.79
1,216.02
968.93
837.27
669.90
862.46
764.90
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
797.79
1,216.02
968.93
837.27
669.90
862.46
764.90
Raw Material Cost
84.14
94.63
97.67
65.31
51.20
57.86
55.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.69
0.66
0.38
0.26
0.12
0.10
0.13
Selling and Distribution Expenses
419.92
558.99
499.22
390.27
343.32
424.20
347.00
Other Expenses
9.30
9.83
9.44
10.49
6.37
9.93
7.74
Total Expenditure (Excl Depreciation)
597.70
752.60
691.71
560.72
458.36
581.51
479.75
Operating Profit (PBDIT) excl Other Income
200.10000000000002
463.40000000000003
277.2
276.6
211.5
281
285.1
Other Income
-10.22
-13.51
-17.52
-5.59
-2.24
8.96
-1.81
Operating Profit (PBDIT)
179.72
489.14
301.11
293.36
235.88
310.54
304.62
Interest
0.69
0.66
0.38
0.26
0.12
0.10
0.13
Exceptional Items
0.00
2.38
0.48
0.55
0.04
-0.41
0.43
Gross Profit (PBDT)
713.66
1,121.39
871.26
771.96
618.69
804.60
709.66
Depreciation
0.00
46.48
46.48
26.59
26.59
24.76
24.76
Profit Before Tax
179.04
444.38
254.73
267.06
209.22
285.27
280.15
Tax
14.55
79.26
16.50
21.29
27.09
11.82
30.35
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
164.49
365.11
238.23
245.77
182.13
273.45
249.81
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
164.49
365.11
238.23
245.77
182.13
273.45
249.81
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
164.49
365.11
238.23
245.77
182.13
273.45
249.81
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,630.39
3,449.58
3,009.26
2,755.39
2,749.28
2,553.32
2,264.55
Earnings per share (EPS)
0.4
0.88
0.59
0.6
0.45
0.67
0.61
Diluted Earnings per share
0.4
0.88
0.59
0.6
0.45
0.67
0.61
Operating Profit Margin (Excl OI)
23.81%
37.51%
28.09%
32.53%
31.58%
32.1%
36.82%
Gross Profit Margin
22.44%
40.37%
31.09%
35.07%
35.2%
35.95%
39.86%
PAT Margin
20.62%
30.03%
24.59%
29.35%
27.19%
31.71%
32.66%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is -34.39% vs 25.50% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is -54.94% vs 53.27% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -62.22% vs 57.78% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 75.00% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Xiamen Amoytop Biotech Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
797.79
0
797.79
Other Operating Income
0.00
0.00
0.00
Total Operating income
797.79
0
797.79
Raw Material Cost
84.14
0
84.14
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.69
0
0.69
Selling and Distribution Expenses
419.92
0
419.92
Other Expenses
9.30
0.00
9.30
Total Expenditure (Excl Depreciation)
597.70
0
597.70
Operating Profit (PBDIT) excl Other Income
200.09
0.00
200.09
Other Income
-10.22
0
-10.22
Operating Profit (PBDIT)
179.72
0
179.72
Interest
0.69
0
0.69
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
713.66
0
713.66
Depreciation
0.00
0
0.00
Profit Before Tax
179.04
0
179.04
Tax
14.55
0
14.55
Provisions and contingencies
0
0
0.00
Profit After Tax
164.49
0
164.49
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
164.49
0
164.49
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
164.49
0
164.49
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,630.39
0
3,630.39
Earnings per share (EPS)
0.40
0
0.40
Diluted Earnings per share
0.40
0
0.40
Operating Profit Margin (Excl OI)
23.81%
0%
0.00
23.81%
Gross Profit Margin
22.44%
0%
0.00
22.44%
PAT Margin
20.62%
0%
0.00
20.62%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 79.78 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -34.39% vs 25.50% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 19.09% vs 22.85% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 16.45 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -54.94% vs 53.27% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -9.67% vs 41.38% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.99 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -62.22% vs 57.78% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -20.24% vs 27.33% in Mar 2025

Quarterly - Interest
Interest 0.07 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 75.00% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 600.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.81%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025